[Optimization of sepsis therapy (literature review)].
Guchev
I A
IA
Klochkov
O I
OI
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D056890:Eukaryota / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D005658:Fungi / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000981:Antiprotozoal Agents